Bristol-Myers: Q1 adjusted EPS almost flat

(CercleFinance.com) - Pharmaceutical company Bristol-Myers Squibb has posted Q1 2021 adjusted EPS that is up 1% at 1.
74 dollar, missing the consensus, while the group confirmed its FY target range of 7.35 to 7.55 dollars.

Its revenues for the first three months of the year rose by 3% to almost 11.1 billion dollars (+1% excluding currency effects). Excluding Covid-19-related buying behaviour a year earlier, revenues rose by 8%.


Copyright (c) 2021 CercleFinance.com. All rights reserved.